StonvexLoading…
StonvexStonvexStonvexCore line items from BOW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $169.31M | $155.69M | $551.59M | $399.91M | $255.98M |
Operating Income | Not available | $20.57M | $67.30M | $49.49M | $30.39M |
Net Income | Not available | $16.01M | $53.79M | $38.94M | $12.34M |
EPS (Diluted) | $0.48 | $0.48 | $1.59 | $1.15 | $0.70 |
Total Assets | Not available | $2.48B | $2.37B | $2.09B | $1.94B |
Total Liabilities | Not available | $2.02B | $1.92B | $1.66B | $1.53B |
Cash & Equivalents | Not available | $97.19M | $193.54M | $197.85M | $114.82M |
Free Cash Flow OCF − CapEx | Not available | $64.17M | $326.02M | $267.38M | $153.91M |
Shares Outstanding | Not available | 32.84M | 32.78M | 32.78M | 32.78M |